Last updated at 18 Jul 2024 04:17 PM
Director
DIN: 00317960
Rahul Bishnoi is currently associated with 4 companies as Director. They serve as a Director at GROWEL REMEDIES LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00317960.Rahul Bishnoi has previously been associated with 6 companies in roles such as Additional Director and Director.Rahul Bishnoi is currently involved in 1 different role. Their most recent position is with MEDICAMEN LIFE SCIENCES PRIVATE LIMITED as a Director. The first company Rahul Bishnoi was appointed to as a director was GROWEL REMEDIES LIMITED. Rahul Bishnoi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rahul Bishnoi is currently associated with 4 companies as Director. They serve as a Director at GROWEL REMEDIES LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00317960.Rahul Bishnoi has previously been associated with 6 companies in roles such as Additional Director and Director.Rahul Bishnoi is currently involved in 1 different role. Their most recent position is with MEDICAMEN LIFE SCIENCES PRIVATE LIMITED as a Director. The first company Rahul Bishnoi was appointed to as a director was GROWEL REMEDIES LIMITED. Rahul Bishnoi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (4)
Current LLPs (0)
Past Companies (6)
6y 3m 3y 2m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GROWEL REMEDIES LIMITED | Director | 15-Oct-1994 |
| SHIVALIK RASAYAN LIMITED | Director | 23-Feb-2002 |
| MEDICAMEN BIOTECH LIMITED | Director | 27-Feb-2016 |
| MEDICAMEN LIFE SCIENCES PRIVATE LIMITED | Director | 12-Aug-2022 |